Vol 65, No 3 (2014)
Original paper
Published online: 2014-06-27

open access

Page views 1898
Article views/downloads 2136
Get Citation

Connect on Social Media

Connect on Social Media

Prognostic markers for the development of type 1 diabetes in first-degree relatives of diabetic patients

Katarzyna Siewko, Anna Popławska-Kita, Beata Telejko, Rafał Maciulewski, Anna Zielińska, Agnieszka Nikołajuk, Maria Górska, Małgorzata Szelachowska
DOI: 10.5603/EP.2014.0024
Endokrynol Pol 2014;65(3):176-180.


Introduction: The aim of this study was to evaluate beta-cell function and insulin resistance in relation to the occurrence of anti-islet antibodies in first degree relatives of patients with type 1 diabetes (T1D).

Material and methods: The group studied consisted of 90 relatives and 60 healthy individuals without a family history of diabetes. An intravenous glucose tolerance test (IVGTT) was performed in all participants and the first phase insulin response index (FPIR) was calculated. Serum concentrations of GADA, IAA and IA-2A were measured by RIA. HOMA-IR and HOMA%B indices were calculated usinga computer calculator from website.

Results: At least one positive antibody was found in 28 relatives (31.1%) but in none of the controls. The most frequently detected antibodieswere IAA (22.2%). The relatives of diabetic patients had significantly higher fasting insulin level (p), significantly lower FPIR index(p), as well as higher HOMA-IR (p) and lower HOMA%B (p) compared to the controls. A positive correlation between IAA concentration and HOMA-IR (r = 0.287, p < 0.005) and a negative correlation between IAA level and HOMA%B (r = –0.226, p < 0.05) were also shown.

Conclusions: Our results confirmed that more than 30% of the first-degree relatives of diabetic patients have positive markers of autoimmunebeta-cell destruction. The study showed also that these individuals, in spite of normal glucose tolerance, have markedly decreased beta-cell secretory reserve and decreased sensitivity to insulin action, strongly suggesting an increased risk for developing diabetes laterin life.